| 2025 |
A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening |
Articolo in rivista |
Go to |
| 2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas |
Articolo in rivista |
Go to |
| 2023 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells |
Articolo in rivista |
Go to |
| 2022 |
Cancer cell targeting by CAR-T cells: A matter of stemness |
Review essay (rassegna critica) |
Go to |
| 2022 |
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy |
Review essay (rassegna critica) |
Go to |
| 2022 |
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells |
Articolo in rivista |
Go to |
| 2022 |
Targeting epigenetic alterations in cancer stem cells |
Review essay (rassegna critica) |
Go to |
| 2022 |
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 |
Articolo in rivista |
Go to |
| 2021 |
Targeting Phosphatases and Kinases: How to Checkmate Cancer |
Articolo in rivista |
Go to |
| 2021 |
Synaptosomes: new vesicles for neuronal mitochondrial transplantation |
Articolo in rivista |
Go to |
| 2021 |
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment |
Review essay (rassegna critica) |
Go to |
